Barbara Hibner
Chief Scientific Officer Decoy Therapeutics
Seminars
Tuesday 28th April 2026
Spotlight Case Study 2: Design & Development of Peptide Conjugate Antiviral Therapeutics
Chief Scientific Officer Decoy Therapeutics